NCT03499444View on ClinicalTrials.gov

A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

June 18, 2019

Study Completion Date

April 13, 2022

Conditions
Advanced Solid Tumor
Interventions
DRUG

Rucaparib

Rucaparib will be administered twice daily

Trial Locations (3)

673-8558

Division of Medical Oncology, Hyogo Cancer Center, Akashi

350-1298

Department of Gynecologic Oncology, Saitama Medical Univeristy international Medical Center, Hidaka

104-0045

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji

All Listed Sponsors
lead

pharmaand GmbH

INDUSTRY

NCT03499444 - A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor | Biotech Hunter | Biotech Hunter